Mount Sinai Ventures
Overview
Mount Sinai Ventures is the corporate venture capital arm of Mount Sinai Health System, dedicated to investing in healthcare innovations that align with the system's mission to provide high-quality, patient-centered care. The fund focuses on a wide range of healthcare sectors, including health technology, medical devices, biotechnology, pharmaceuticals, digital health, medical services, diagnostics, medical equipment, consumer health, health IT, medical research, healthcare services, healthcare IT, healthcare analytics, healthcare infrastructure, healthcare supply chain, healthcare logistics, healthcare real estate, and healthcare education. By partnering with innovative companies, Mount Sinai Ventures aims to enhance the delivery of healthcare services and improve patient outcomes. The investment strategy of Mount Sinai Ventures encompasses various stages of company development, from seed and early-stage investments to growth, late-stage, pre-IPO, buyout, turnaround, and distressed situations. This approach allows the fund to support companies at different points in their lifecycle, providing the necessary resources and expertise to foster growth and success. The geographical focus is primarily on the United States, reflecting the health system's commitment to advancing healthcare within the country. Through strategic investments, Mount Sinai Ventures seeks to drive innovation in the healthcare sector, leveraging the expertise and resources of Mount Sinai Health System to support the commercialization and scaling of groundbreaking healthcare solutions. The fund's portfolio includes a diverse array of companies that contribute to the advancement of medical technologies, patient care services, and healthcare infrastructure, aligning with the overarching goal of transforming healthcare delivery and improving patient outcomes.
Investment Focus
- Innovative healthcare solutions
- Alignment with Mount Sinai Health System's mission
- Potential for scalability and impact
- Strong management teams
- Clear regulatory pathways
- Sustainable business models
- Commitment to improving patient outcomes
- Technological advancements in healthcare
- Addressing unmet medical needs
- Enhancing healthcare delivery efficiency
- Improving patient access to care
- Advancements in medical research
- Development of new medical devices
- Innovations in healthcare services
- Progress in health IT solutions
- Advancements in diagnostics
- Improvements in medical equipment
- Innovations in consumer health products
- Advancements in health IT infrastructure
- Innovations in healthcare analytics
Portfolio Companies
Reach Mount Sinai Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Mount Sinai Ventures
What sectors does Mount Sinai Ventures invest in?
Mount Sinai Ventures invests in Healthcare, Healthcare Services, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in New York, United States. Mount Sinai Ventures is listed as a corporate vc in the ConnectSafely investor database.
What stage does Mount Sinai Ventures invest at?
Mount Sinai Ventures backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Mount Sinai Ventures invest in?
Mount Sinai Ventures invests across United States.
What companies has Mount Sinai Ventures invested in?
Mount Sinai Ventures's portfolio includes Ambulatory Surgery Centers, Urgent Care Centers, Management Service Organizations and Health Technology Companies.
Last updated · Source: ConnectSafely investor database
